central cardiovascular effects of the sodium-potassium adenosine triphosphatase ( na+ , k+-atpase ) inhibitor , ouabain , were investigated by injecting it intracerebroventricularly ( icv ) using conscious wistar rats .
C0001479
sodium-potassium adenosine triphosphatase
C0001473
atpase